• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.24% Nasdaq Up 1.35%

    Stemline Therapeutics, Inc. (STML)

    -NasdaqCM
    8.97 Up 0.26(2.99%) 1:52PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:8.71
    Open:8.82
    Bid:8.96 x 200
    Ask:9.01 x 200
    1y Target Est:41.50
    Beta:-1.5437
    Earnings Date:Nov 10 - Nov 16 (Est.)
    Day's Range:8.67 - 9.03
    52wk Range:8.31 - 18.94
    Volume:31,634
    Avg Vol (3m):92,775
    Market Cap:161.23M
    P/E (ttm):N/A
    EPS (ttm):-2.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for STML

    Comparison

    Symbol% ChgMkt Cap
    STMLUp 2.99%161.23M
    OMEDUp 1.92%590.12M
    VSTMUp 2.68%225.81M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):350.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.22
    Quarterly EPS Est (Sep-15) :-0.59
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback